Kilitch Drugs (india) Ltd. Right Issue

₹49.93 Cr BSE, NSE 23 Jul 2025 – 21 Aug 2025

Closed Ratio: 2 : 23 BSE, NSE
HomeRight Issue › Kilitch Drugs (india) Ltd.
← Back to List
Issue Price
₹357.00
Face Value
₹10.00
Issue Size (Shares)
1,398,463
Issue Size (₹ Cr.)
₹49.93
📅 Right Issue Timetable
Last Date to Buy SharesMon, Jul 14, 2025
Record DateTue, Jul 15, 2025
Credit of Rights EntitlementsWed, Jul 16, 2025
Bid/Offer Opens OnWed, Jul 23, 2025
Issue Open DateWed, Jul 23, 2025
Renunciation Last DateMon, Aug 18, 2025
Bid/Offer Closes OnThu, Aug 21, 2025
Issue Close DateThu, Aug 21, 2025
Deemed Date of AllotmentFri, Aug 22, 2025
Credit DateTue, Aug 26, 2025
Listing DateThu, Aug 28, 2025
📋 Right Issue Details
Issue Size (Shares)1,398,463
Issue Size (Amount)₹49.93 Cr.
Issue Price₹357.00 per share
Face Value₹10.00 per share
Entitlement Ratio2 : 23
Listing AtBSE, NSE
Terms of PaymentThe full amount of the Issue Price Rs 357/- will be payable on application. The full amount of the Issue Price Rs 357/- will be payable on application.
📊 Company Financials (Restated)
Period Ended2025-03-312024-03-31FY I
Income198.32154.37
EBITDA
Net Worth202.33176.29
Reserves & Surplus186.25160.21

Amount in ₹ Crore

🎯 Objects of the Issue
#ObjectEst. Amount (₹ Cr.)
1Funding Capital Expenditure for Greenfield Project at Pen, Maharashtra, India
2General Corporate Purposes.
🏢 About the Company
Incorporated in 1992, Kilitch Drugs (India) Ltd, specializes in manufacturing and exporting pharmaceutical formulations. It serves over 38 countries, focusing on injectables, oral solids, nutraceuticals, and ophthalmic products across emerging markets.

The company operates facilities in India and Ethiopia. Its upcoming Khopoli plant will manufacture diabetes, weight-loss drugs, and biosimilars, with plans for US-FDA and EU approvals in future phases.

The company engages in the development, manufacturing, and marketing of a wide range of products: oral solids, injectables, ophthalmic, nasal formulations, nutritional supplements, medical devices, and cosmetics.
📞 Company Contact
CompanyKilitch Drugs (india) Ltd.
AddressC-301/2 MIDC,
TTC Industrial Area,
Pawane Village, Thane,
Mumbai, 400705
Phone02261214100
Emailpushpanyoupane@kilitch.com
WebsiteVisit ↗
📝 Registrar
NameMUFG Intime India Pvt.Ltd.
Phone022-49186000
Emailkilitchdrugs.rights@in.mpms.mufg.com
WebsiteVisit ↗